REPORT ID 6519

United States Non Receptor Tyrosine Protein Kinase TYK2 Market Report 2019

Publish Date
2019
Pages
96
Format
Electronic (PDF)

In this report, the United States Non Receptor Tyrosine Protein Kinase TYK2 market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Non Receptor Tyrosine Protein Kinase TYK2 in these regions, from   2019 to 2025 (forecast).

United States Non Receptor Tyrosine Protein Kinase TYK2 market competition by top manufacturers/players, with Non Receptor Tyrosine Protein Kinase TYK2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Array BioPharma Inc
    Bristol-Myers Squibb Company
    Nimbus Therapeutics LLC
    Pfizer Inc
    Portola Pharmaceuticals Inc
    Sareum Holdings Plc
    Takeda Pharmaceutical Company Ltd
    Theravance Biopharma Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ARRY-624
    BMS-986165
    Cerdulatinib
    NDI-031232
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Follicular Lymphoma
    Hypersensitivity
    Lupus Nephritis
    Marginal Zone B-cell Lymphoma
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Non Receptor Tyrosine Protein Kinase TYK2 Market  Report 2019
1 Non Receptor Tyrosine Protein Kinase TYK2 Overview
    1.1 Product Overview and Scope of Non Receptor Tyrosine Protein Kinase TYK2
    1.2 Classification of Non Receptor Tyrosine Protein Kinase TYK2 by Product Category
        1.2.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 ARRY-624
        1.2.4 BMS-986165
        1.2.5 Cerdulatinib
        1.2.6 NDI-031232
        1.2.7 Others
    1.3 United States Non Receptor Tyrosine Protein Kinase TYK2 Market by Application/End Users
        1.3.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Follicular Lymphoma
        1.3.3 Hypersensitivity
        1.3.4 Lupus Nephritis
        1.3.5 Marginal Zone B-cell Lymphoma
        1.3.6 Others
    1.4 United States Non Receptor Tyrosine Protein Kinase TYK2 Market by Region
        1.4.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Non Receptor Tyrosine Protein Kinase TYK2 Status and Prospect ( 2014-2024)
        1.4.3 Southwest Non Receptor Tyrosine Protein Kinase TYK2 Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Non Receptor Tyrosine Protein Kinase TYK2 Status and Prospect ( 2014-2024)
        1.4.5 New England Non Receptor Tyrosine Protein Kinase TYK2 Status and Prospect ( 2014-2024)
        1.4.6 The South Non Receptor Tyrosine Protein Kinase TYK2 Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Non Receptor Tyrosine Protein Kinase TYK2 Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Non Receptor Tyrosine Protein Kinase TYK2 ( 2014-2024)
        1.5.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue and Growth Rate ( 2014-2024)

2 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Competition by Players/Suppliers
    2.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Non Receptor Tyrosine Protein Kinase TYK2 Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Competitive Situation and Trends
        2.4.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Concentration Rate
        2.4.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base Distribution, Sales Area, Product Type

3 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales and Market Share by Region ( 2014-2019)
    3.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Non Receptor Tyrosine Protein Kinase TYK2 Price by Region ( 2014-2019)

4 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Non Receptor Tyrosine Protein Kinase TYK2 Price by Type ( 2014-2019)
    4.4 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Type ( 2014-2019)

5 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales (Volume) by Application ( 2014-2019)
    5.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales and Market Share by Application ( 2014-2019)
    5.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Non Receptor Tyrosine Protein Kinase TYK2 Players/Suppliers Profiles and Sales Data
    6.1 Array BioPharma Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb Company
        6.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Nimbus Therapeutics LLC
        6.3.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer Inc
        6.4.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Portola Pharmaceuticals Inc
        6.5.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Sareum Holdings Plc
        6.6.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Takeda Pharmaceutical Company Ltd
        6.7.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Theravance Biopharma Inc
        6.8.2 Non Receptor Tyrosine Protein Kinase TYK2 Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview

7 Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Cost Analysis
    7.1 Non Receptor Tyrosine Protein Kinase TYK2 Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Non Receptor Tyrosine Protein Kinase TYK2

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Non Receptor Tyrosine Protein Kinase TYK2 Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Non Receptor Tyrosine Protein Kinase TYK2 Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Non Receptor Tyrosine Protein Kinase TYK2 Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Non Receptor Tyrosine Protein Kinase TYK2 Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer